Related Experiment Videos
[Psychotropic drug-induced myoclonus]
1Evangelische Nervenklinik, Klinikbereich Neurologie, Remscheid-Lüttringhausen.
Psychiatrische Praxis
|March 1, 1995
Summary
Antidepressant or neuroleptic-induced myoclonus may indicate increased cerebral excitability or epilepsy. Further neurophysiological testing, including electroencephalography (EEG) and somatosensory evoked potentials (SSEP), can help assess seizure risk.
Area of Science:
- Neurology
- Neurophysiology
- Epileptology
Background:
- Myoclonus can be a symptom of various neurological conditions.
- Distinguishing drug-induced myoclonus from other causes is crucial for diagnosis and management.
- Increased cerebral excitability may underlie certain types of myoclonus.
Observation:
- Five case studies explored the link between drug-induced myoclonus and epilepsy.
- Electroencephalography (EEG) recordings in reported cases showed epilepsy-specific potentials.
- Somatosensory evoked potentials (SSEP) revealed N1/P1 amplitude increases.
Findings:
- Drug-induced myoclonus, when physiological causes are excluded, often suggests subtle signs of increased cerebral excitability.
- This presentation can represent an epileptic fragment or, in some cases, myoclonus epilepsy.
- EEG and SSEP findings may serve as diagnostic criteria for seizure risk assessment.
Implications:
- Further neurophysiological examinations, particularly back-averaging techniques, are recommended for comprehensive evaluation.
- EEG and SSEP analysis can aid in determining the risk of epileptic seizures associated with specific myoclonus types.
- These findings underscore the importance of considering drug-induced myoclonus as a potential indicator of underlying epileptiform activity.